---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-157867"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2025-07-11T23:59:59+00:00"
generated_at: "2026-05-18T06:57:40.081493+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ISS and Glass Lewis recommend Ikena stockholders vote FOR Inmagene merger

## Summary
- Institutional Shareholder Services (ISS) and Glass Lewis recommend voting FOR share issuance related to merger with Inmagene.
- Ikena's Annual Meeting is July 15, 2025; record date was May 22, 2025.
- Inmagene's lead candidate is IMG-007, a nondepleting anti-OX40 mAb for immune & inflammatory diseases.
- CEO Mark Manfredi cited IMG-007's potential to build shareholder value in I&I space.
- Proxy includes seven proposals; all votes are important for merger approval.

## SEC filing metadata
- accession: 0001193125-25-157867
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2025-07-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312525157867/0001193125-25-157867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312525157867/d826245d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-157867
- JSON: https://secwatch.observer/filing/0001193125-25-157867.json
- Plain text: https://secwatch.observer/filing/0001193125-25-157867.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.